These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8994247

  • 1. Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
    Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE.
    Prenat Diagn; 1996 Dec; 16(12):1115-9. PubMed ID: 8994247
    [Abstract] [Full Text] [Related]

  • 2. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 3. Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects.
    Watt HC, Wald NJ.
    Prenat Diagn; 1998 Aug; 18(8):842-5. PubMed ID: 9742575
    [Abstract] [Full Text] [Related]

  • 4. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
    Crossley JA, Berry E, Aitken DA, Connor JM.
    Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Triple marker screening in native Japanese women.
    Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, Bradley LA, Canick JA, Krasikov NE, Ponting NR, Grier RE.
    Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M, Christiaens GC, van der Schouw YT, Hagenaars AM, de Pater JM, Visser GH.
    Ned Tijdschr Geneeskd; 1998 Feb 21; 142(8):409-15. PubMed ID: 9562776
    [Abstract] [Full Text] [Related]

  • 9. Maternal serum screening.
    Carroll JC.
    Can Fam Physician; 1994 Oct 21; 40():1756-64. PubMed ID: 7524838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A.
    Prenat Diagn; 1997 Sep 21; 17(9):861-6. PubMed ID: 9316131
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM, Dupuis HM.
    Ned Tijdschr Geneeskd; 1993 Jun 26; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract] [Full Text] [Related]

  • 17. Maternal serum triple analyte screening in pregnancy.
    Graves JC, Miller KE, Sellers AD.
    Am Fam Physician; 2002 Mar 01; 65(5):915-20. PubMed ID: 11898965
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
    Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, Ho PK.
    Prenat Diagn; 1998 Jun 01; 18(6):585-89. PubMed ID: 9664604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.